ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OMG Oxford Metrics Plc

54.60
1.80 (3.41%)
23 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Oxford Metrics Plc OMG London Ordinary Share
  Price Change Price Change % Share Price Last Trade
1.80 3.41% 54.60 16:35:11
Open Price Low Price High Price Close Price Previous Close
53.00 53.00 55.00 54.60 52.80
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Oxford Metrics OMG Dividends History

Announcement Date Type Currency Dividend Amount Ex Date Record Date Payment Date
03/12/2024FinalGBP0.032512/12/202413/12/202405/03/2025
05/12/2023FinalGBP0.027514/12/202315/12/202314/02/2024
06/12/2022FinalGBP0.02529/12/202230/12/202223/02/2023
02/12/2021FinalGBP0.0209/12/202110/12/202123/02/2022
03/12/2020FinalGBP0.01810/12/202011/12/202005/03/2021

Top Dividend Posts

Top Posts
Posted at 20/12/2024 09:47 by petewy
Results look OK. Divi up
Posted at 11/12/2024 16:34 by simon gordon
PI World - 11/12/24:

Talking Tech – Episode 13: Oxford Metrics (OMG) & FD Technologies (FDP)
Posted at 05/12/2024 20:56 by rambutan2
From city Wire today:

Oxford Metrics (OMG), the developer of smart sensors, is making ‘operational progress’ despite cyclical challenges, says Deutsche Numis.

Analyst Tintin Stormont retained her ‘buy’ recommendation and increased the target price from 95p to 110p on the stock, which rose 2.8% to 59.8p yesterday, but has tumbled 44.6% in 2024 to date.

Full-year 2024 revenues came in 6% lower at £41.5m year-on-year, with profit before tax falling to £3.7m from £7.5m the year before. Stormont said that all the figures were ‘slightly above our revised expectations’ after the September warning of over-extended buying cycles.

‘As expected, entertainment has been impacted the most, reflecting the widely reported slowdown in the global games industry and subsequent content creation contraction,’ said Stormont.

‘Engineering and life sciences were also impacted, reflecting delays in academic funding. The group ended the period with just over £50m of cash. Post period-end the group announced a return of cash of £6m via a share buyback.’
Posted at 05/12/2024 10:24 by sev22
Analysts are being too cautious with this software stock.

Earnings downgrade hurts the smart sensing and software group, but it’s still well placed to recover.

Published on December 3, 2024
by Simon Thompson

*Full-year revenue down 6 per cent to £41.5mn
*Adjusted pre-tax profit halved to £3.7mn
*Underlying earnings per share (EPS) down from 5.3p to 3p
*Dividend per share up 18 per cent to 3.25p
*Closing net cash of £50.7mn (39p)
*5.5 per cent dividend yield

Smart sensing and software group Oxford Metrics (OMG:59.5p) issued a profit warning at the end of its financial year, so the sharp fall in profits had been well flagged (‘Oxford Metrics’ warning hits shares – but all is not lost’, 23 September 2024).

The issue is that customers are being more cautious, which has lengthened buying cycles and pushed several opportunities in the sales pipeline into the new financial year. In particular, the entertainment sector was impacted by the slowdown in the global games industry and subsequent contraction in content creation. The segment reported 23 per cent lower revenue of £15.9mn, representing 38 per cent of the group total. Both the life sciences and engineering segments, accounting for 56 per cent of Oxford Metrics’ annual revenue, performed better but still reported single-digit revenue declines due to delays in academic funding.

So, although revenue was at the top of the revised £40mn-£42mn range in the 12 months to 30 September 2024, it was still well below last year’s revenue of £44.2mn. The impact on earnings was accentuated because Oxford Metrics is a high-margin business that generates a gross margin of 67 per cent, a contributory factor behind the 51 per cent decline in adjusted pre-tax profit to £3.7mn on 6 per cent lower annual revenue.

Prospects for the new financial year.

Industrial Vision Systems (IVS), a specialist in developing machine vision software systems that was acquired 13 months ago, has closed several large deals worth more than £1.3mn in sales, which has contributed to a healthy order book. The group’s smart manufacturing division has made a good start, too, having made a maiden £2.9mn revenue contribution in the 2024-25 financial year.

In addition, the board is deploying the group’s bumper cash pile to make earnings-accretive bolt-on acquisitions. The recent acquisition of Gloucester-based The Sempre Group, a measurement specialist that helps blue-chip manufacturers be more efficient and improve quality, looks like a smart deal (‘This company's recovery potential is severely underrated’, 4 November 2024). It is part of Oxford Metrics' drive into smart manufacturing and offers synergies with IVS.

Sempre offers a range of bespoke metrology solutions to address quality and automation challenges in the aerospace, automotive, medical, energy and precision engineering sectors. For instance, its technology is used to measure the wingspans for aircraft and precision of bone screws and joint implants. Sempre was purchased for £5.5mn, representing a reasonable multiple of eight times the 2023 pre-tax profit of £0.7mn.

Impact on forecasts.

Although analysts at Deutsche Numis see some encouraging pockets of activity, they feel it is prudent to reflect more caution in their forecasts until there is more consistent demand recovery.

So, even after factoring in a maiden £0.8mn operating profit contribution from Sempre, a doubling of IVS operating profit to £0.6mn, £1.5mn of interest income and a £0.3mn rise in central overheads to £3.8mn, the brokerage only expects adjusted pre-tax profit to edge up to £3.9mn (17 per cent downgrade) on 15 per cent higher revenue of £47.9mn in the 12 months to 30 September 2025. Expect net cash of £46.7mn (30 November 2024) to fall to £41.8mn (30 September 2025) after factoring in a £6mn share buy-back programme and the Sempre acquisition.

The downgrade is disappointing, but it’s already factored into the valuation as the group’s enterprise valuation of £30mn equates to 12.5 times the bottom-of-the-cycle operating profit estimates of £2.4mn for the new financial year.

Indeed, Deutsche Numis’s target price of 95p (from 110p) still supports 61 per cent share price upside. Moreover, shareholders will be pressing management to deploy more of the cash pile on bolt-on acquisitions, so there is scope for mergers and acquisition-driven upgrades as the year progresses. I certainly would not be selling out the high-yielding shares at this depressed level. HOLD.
Posted at 03/12/2024 07:28 by lennonsalive
OMG reported FY24 revenue of £41.5m, down 6% YOY, and adjusted PBT of £3.7m, down 51%. Net cash at £50.7m. H2 impacted by delayed purchases. Dividend up 18%.
Posted at 04/11/2024 17:09 by boystown
Tipped by Simon Thompson today:

This company's recovery potential is severely underrated

- £5.5mn earnings-accretive acquisition
- £6mn share buy-back programme
- Rated on eight times operating profit estimates to enterprise valuation

Shares in smart sensing and software group Oxford Metrics (OMG: 59.5p) have yet to react to the smart-looking acquisition of Gloucester-based The Sempre Group, a measurement specialist that helps blue-chip manufacturers be more efficient and improve quality – ultimately saving time and money.

Trusted by more than 25 well-known manufacturers including Renishaw, Micro-Vu and Jenoptik, Sempre offers its customers an extensive range of bespoke metrology solutions to address quality and automation challenges in the aerospace, automotive, medical, energy and precision engineering sectors. For instance, customers use its technology for the measurement of wingspans for airliners and measuring compliance and the precision of bone screws and joint implants.

The acquisition is part of Oxford Metrics' drive into smart manufacturing and offers synergies with last autumn’s acquisition of Industrial Vision Systems (IVS), a specialist in developing machine vision software systems. Sempre will benefit from having access, advice and the resources to scale and expand into new markets and geographies, while IVS will gain access to Sempre's established sales and services organisation and benefit from its industry knowledge, customers, products and markets.

Importantly, Sempre’s directors will continue to lead the business forward, and founder and seller Mike John will stay on in a consulting role to ensure a smooth integration. Oxford Metrics is paying a £5mn cash consideration on completion, and there is a £0.5mn contingent earn-out based on performance targets being achieved. That seems fair given that Sempre has delivered annualised revenue growth of 8 per cent over the past four years and reported pre-tax profit of £0.7mn on revenue of £6.5mn in 2023. Current trading is consistent with a further improvement in performance, so the exit multiple of eight times 2023 pre-tax profit is reasonable, as is a multiple of 3.3 times book value.

Immediately earnings enhancing

Furthermore, the deal is immediately earnings enhancing. That’s because Oxford Metrics ended the 2024 financial year with net cash of £50mn (38p), so will be funding the deal from its cash resources. Alongside the announcement, Oxford Metrics also announced a £6mn on-market share buy programme, a sensible use of its cash pile given that it should also be accretive to earnings per share (EPS).

Although analysts at Progressive Equity Research have not adjusted their forecasts ahead of the group’s annual results on 3 December 2024, clearly there is upside to their current expectations of a sharp recovery in adjusted pre-tax profit from £3.4mn to £4.7mn and underlying EPS from 2.2p to 3p in the 12 months to 30 September 2025. A near-11-month contribution from Sempre should add £0.65mn to that profit forecast alone.

It’s worth flagging that Progressive Equity expects the £77.6mn market capitalisation group to deliver free cash flow of £9.6mn (7.4p) from operating cash flow of £10.2mn in the current financial year, so part of the investment in the acquisition and share buybacks will be funded from internal cash flow.

In fact, Oxford Metrics could buy back 10mn shares in issue for £6mn and still have a retained cash pile of £42mn by September 2025 after factoring in the £5mn upfront cash cost of acquiring Sempre, £3.6mn cash cost of a dividend that underpins a 5 per cent prospective dividend yield, and £2.5mn of other investments. However, shareholders are likely to be pressing the board to make further similar acquisitions to accelerate the profit recovery after the recent profit warning (‘Oxford Metrics’ warning hits shares – but all is not lost’, 24 September 2024).

Trading on price-to-book value parity and on eight times operating profit estimates to enterprise valuation, prospects for a 50 per cent-plus earnings recovery in the 2024-25 financial year (after factoring in Sempre’s contribution) is simply not in the price. For good measure, there is positive divergence on the chart, suggesting that the share price has bottomed out and a break-out from a base formation could be on the cards. A close above the 65p price level would be confirmation. Recovery buy.
Posted at 31/10/2024 09:20 by rivaldo
Nice - J O Hambro Capital Management Limited have been buying and taken their stake above 3%, with 4m shares:
Posted at 29/10/2024 19:48 by rossco
I have previously held OMG.
I almost bought back in in June when an “profits in line” announcement was made and the price fell below 100p.
Fortunately I decided just to monitor the price and with the news in September of profits going to be materially below expectations I have left well alone.
Looking at Progressive’s forecast of PBT of 3.4m I reckon that 70% will be finance income from the hoard of cash.
Can’t say I am impressed with board announcements since CEO was appointed in September last year.
Even the share buyback is not stopping the share price decline.

Going to wait until the next results announcement before making a decision to buy.
Posted at 12/9/2024 15:13 by nchanning
Broker did say just in June that OMG has more than 90% visibility on full year revenues , year end cash pile of 59£ million . Even if you get a profit warning now it's unlikely to be a big one with that kind of visibility how low can the price really go ? The enterprise value has gone from 90m to 50m with the only news being an inline update with no changes to forecasts . If you wake up to a bad profit warning RNS saying revenues marked down from 49m to 44m and PBT from 8m to 5m , surely you'd say that's in the price already ....
Posted at 09/9/2024 10:59 by nakedmolerat
i am looking at this again because of the price. mcap at 103, half of that is cash.

right, interim results from july

revenue up, profit down, dividend increase, cash down, but they did make purchase if i remember and is that included or is the divi eating the cash?

the problem for me is the order book, h1 fy 2024 3 million v 2023 11.3 million
it's below the 200 moving average and could fall past the current point at where it has been before
income fell from games

in the interim they state

Oxford Metrics is well placed to deliver full year results in line with current market expectations.

so, inline, but what is fy 2024 forecast?

i'm fraid it's no from me for investing here until i see buyers, which will come on order book or purchases.

thoughts?

Your Recent History

Delayed Upgrade Clock